Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We propose that postmortem tissue is an underutilized substrate that may be used to translate genetic and/or preclinical studies, particularly for neuropsychiatric illnesses with complex etiologies. Postmortem brain tissues from subjects with schizophrenia have been extensively studied, and thus serve as a useful vehicle for illustrating the challenges associated with this biological substrate. Schizophrenia is likely caused by a combination of genetic risk and environmental factors that combine to create a disease phenotype that is typically not apparent until late adolescence. The complexity of this illness creates challenges for hypothesis testing aimed at understanding the pathophysiology of the illness, as postmortem brain tissues collected from individuals with schizophrenia reflect neuroplastic changes from a lifetime of severe mental illness, as well as treatment with antipsychotic medications. While there are significant challenges with studying postmortem brain, such as the postmortem interval, it confers a translational element that is difficult to recapitulate in animal models. On the other hand, data derived from animal models typically provide specific mechanistic and behavioral measures that cannot be generated using human subjects. Convergence of these two approaches has led to important insights for understanding molecular deficits and their causes in this illness. In this review, we discuss the problem of schizophrenia, review the common challenges related to postmortem studies, discuss the application of biochemical approaches to this substrate, and present examples of postmortem schizophrenia studies that illustrate the role of the postmortem approach for generating important new leads for understanding the pathophysiology of severe mental illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
Fanselow, M. S., & Dong, H.-W. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.031 · Cited by 3,358 · cited 1×
“There may be marked variability in gene expression and function depending on the precise boundaries of the sample (Fanselow and Dong, 2010).”
Background(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010 · cited 1×
“…analysis identified four SNPs across five disorders in 430 000 patients and B30 000 controls, which reached genome-wide significance, suggesting that severe mental illnesses such as schizophrenia, bipolar disorder, and depression share common polygenic risk factors (Smoller et al, 2013).”
BackgroundLong-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
Citri, A., & Malenka, R. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301559 · Cited by 2,323 · cited 2×
“…and anchoring of receptor complexes in lipid rafts permits partitioning of proteins into subcellular microdomains, which include specialized compartments that facilitate critical cellular functions such as long-term potentiation and long-term depression (Citri and Malenka, 2008; Shan et al, 2013).”
BackgroundBendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254 · cited 1×
“Perhaps the strongest genetic data come from the DISC translocation study (Millar et al, 2000).”
BackgroundNMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 2×
“receptor trafficking and the roles of receptor-interacting proteins like PSD95 (Lau and Zukin, 2007).”
BackgroundDiscovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms
Chen, L., Chetkovich, D. M., Petralia, R. S., Sweeney, N. T., Kawasaki, Y., Wenthold, R. J., Bredt, D. S., & Nicoll, R. A. (2000) · Nature · doi:10.1038/35050030 · Cited by 1,111
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · cited 1×
“Polymorphisms in the gene affect cognition in normal individuals, but large GWAS studies did not find an effect for DISC1 in schizophrenia (Badner and Gershon, 2002; Devon et al, 2001; Hodgkinson et al, 2004).”
BackgroundThe interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking
Bats, C., Groc, L., & Choquet, D. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.030 · Cited by 590
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators
Bodenmiller, B., Zunder, E. R., Finck, R., Chen, T. J., Savig, E. S., Bruggner, R. V., Simonds, E. F., Bendall, S. C., Sachs, K., Krutzik, P. O., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2317 · Cited by 546
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Lisman (2001) · doi:10.1016/s0896-6273(01)00364-6 · Cited by 480 · cited 1×
“Lateral translocation of this receptor complex to the PSD is the mechanism by which synaptic responses are strengthened during some types of long-term potentiation (Contractor and Heinemann, 2002; Lisman and Zhabotinsky, 2001; McGee and Bredt, 2003)(Figure 3).”
BackgroundSocial interaction and sensorimotor gating abnormalities in mice lacking Dvl1
Lijam, N., Paylor, R., McDonald, M. P., Crawley, J. N., Deng, C.-X., Herrup, K., Stevens, K. E., Maccaferri, G., McBain, C. J., Sussman, D. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80354-2 · Cited by 470
Leonard, A. S., Davare, M. A., Horne, M. C., Garner, C. C., & Hell, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19518 · Cited by 421
Human postmortem tissue: What quality markers matter?
Stan, A. D., Ghose, S., Gao, X.-M., Roberts, R. C., Lewis-Amezcua, K., Hatanpaa, K. J., & Tamminga, C. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.025 · Cited by 361
Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., & Pearson, R. C. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12102-a · Cited by 342 · cited 4×
“Several studies have reported diminished mRNA quality associated with prolonged agonal states (Barton et al, 1993; Durrenberger et al, 2010; Harrison et al, 1991, 1995; Kingsbury et al, 1995; Lipska et al, 2006a, b; Tomita et al, 2004a, b; Vawter et al, 2006; Weickert et al, 2010).”
BackgroundInfluentialTomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J., Overman, K. M., Atz, M. E., Myers, R. M., Jones, E. G., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.013 · Cited by 331 · cited 2×
“Several studies have reported diminished mRNA quality associated with prolonged agonal states (Barton et al, 1993; Durrenberger et al, 2010; Harrison et al, 1991, 1995; Kingsbury et al, 1995; Lipska et al, 2006a, b; Tomita et al, 2004a, b; Vawter et al, 2006; Weickert et al, 2010).”
BackgroundAltar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T. A., Bullard, J., Yokoe, H., Webster, M. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.031 · Cited by 318 · cited 1×
“…experiments found changes in individual genes such as ubiquitin specific protease 14 and ubiquitin C-terminal transferase, as well as changes in canonical pathways such as the ubiquitin proteasome pathway (Altar et al, 2005; Bousman et al, 2010; Middleton et al, 2002; Vawter et al, 2001).”
BackgroundKim, M. J., Futai, K., Jo, J., Hayashi, Y., Cho, K., & Sheng, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.007 · Cited by 278
Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin
Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.042 · Cited by 270
Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., Lopez, J. F., Avelar, A., Shokoohi, V., Chung, T., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh065 · Cited by 261
Pierri, J. N., Volk, C. L. E., Auh, S., Sampson, A., & Lewis, D. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.466 · Cited by 257
Lewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253 · cited 1×
“…levels of dopamine receptor type 2 (D2) blockade; preterminal and/or presynaptic dopamine receptors modulate glutamate and gammaaminobutyric acid (GABA) neurotransmission, and it is through these other neurotransmitters that D2 receptor antagonists likely have their effects (Lewis et al, 2004).”
BackgroundAshby, M. C., De La Rue, S. A., Ralph, G. S., Uney, J., Collingridge, G. L., & Henley, J. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1042-04.2004 · Cited by 244
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227 · cited 1×
“One approach to get around this issue has been pooling of samples; pooled samples are assayed and help generate specific hypotheses that may be tested with smaller quantities of tissue (English et al, 2009; English et al, 2011; Pennington et al, 2008).”
BackgroundKristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220
Self-citationYee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
Scott, D. B., Blanpied, T. A., & Ehlers, M. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00250-8 · Cited by 186 · cited 1×
“…REVIEWS at best only indirectly reflect changes in kinase activity (Broadbelt and Jones, 2008; Castillo et al, 2010; Emamian et al, 2004; Funk et al, 2012; Kunii et al, 2011; Kunii et al, 2011; Scott et al, 2003).”
BackgroundHardy, J. A., Wester, P., Winblad, B., Gezelius, C., Bring, G., & Eriksson, A. (1985) · Journal of Neural Transmission · doi:10.1007/bf01251916 · Cited by 185 · cited 1×
“0) are typically not included in postmortem studies (Durrenberger et al, 2010; Ervin et al, 2007; Hardy et al, 1985; Harrison et al, 1995; Kingsbury et al, 1995; Tomita et al, 2004a,b).”
BackgroundBehavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia
Szumlinski, K. K., Lominac, K. D., Kleschen, M. J., Oleson, E. B., Dehoff, M. H., Schwartz, M. K., Seeberg, P. H., Worley, P. F., & Kalivas, P. W. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00120.x · Cited by 181
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Lipska, B. K., Peters, T., Hyde, T. M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C. S., Matsumoto, M., Sawa, A., Straub, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl040 · Cited by 168 · cited 1×
“Several studies have reported diminished mRNA quality associated with prolonged agonal states (Barton et al, 1993; Durrenberger et al, 2010; Harrison et al, 1991, 1995; Kingsbury et al, 1995; Lipska et al, 2006a, b; Tomita et al, 2004a, b; Vawter et al, 2006; Weickert et al, 2010).”
BackgroundEffects of Antemortem and Postmortem Variables on Human Brain mRNA Quality: A BrainNet Europe Study
Durrenberger, P. F., Fernando, S., Kashefi, S. N., Ferrer, I., Hauw, J.-J., Seilhean, D., Smith, C., Walker, R., Al-Sarraj, S., Troakes, C., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c7e32f · Cited by 161 · cited 2×
“Several studies have reported diminished mRNA quality associated with prolonged agonal states (Barton et al, 1993; Durrenberger et al, 2010; Harrison et al, 1991, 1995; Kingsbury et al, 1995; Lipska et al, 2006a, b; Tomita et al, 2004a, b; Vawter et al, 2006; Weickert et al, 2010).”
BackgroundGuo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120
Trinh, J. V., Nehrenberg, D. L., Jacobsen, J. P. R., Caron, M. G., & Wetsel, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00165-9 · Cited by 113
DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia
Szeszko, P. R., Hodgkinson, C. A., Robinson, D. G., DeRosse, P., Bilder, R. M., Lencz, T., Burdick, K. E., Napolitano, B., Betensky, J. D., Kane, J. M., et al. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2007.10.011 · Cited by 95
Cai, C., Coleman, S. K., Niemi, K., & Keinänen, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204354200 · Cited by 94
Le Grevès, M., Zhou, Q., Berg, M., Le Grevès, P., Fhölenhag, K., Meyerson, B., & Nyberg, F. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0438-2 · Cited by 92
Tissue preparation and banking
Webster, M. J. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)58001-x · Cited by 67
Cited by
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P., & Abbott, N. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 307
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
“As recently convincingly argued (McCullumsmith et al., 2014), post-mortem tissue is an under-used substrate for genetic and/or”
Osimo, E. F., Beck, K., Reis Marques, T., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0041-5 · Cited by 268
Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14122-0 · Cited by 243
Metadata
- Authors
- McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador-Woodruff, J. H.
- Venue
- Neuropsychopharmacology
- Published
- 2013-10-04
- Volume
- 39
- Issue
- 1
- Pages
- 65-87
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2032503223
- Cited by
- 111
- References
- 43
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.